The aim of this paper was to evaluate the immune reconstitution of HIV-1 patients subjected to highly active antiretroviral therapy (HAART) for two years or more according to CD 45 infected patients were evaluated, 13 with treatment indication but untreated (G1), 9 subjected to HAART for 5-7 months (G2), and 15 treated for two years or more (G3); both treated groups used medication regularly and without failure. Forty-nine normal individuals were studied as controls (GC-1 and GC-2). There was a tendency (p<0.10)
INTRODUCTION
The introduction of highly active antiretroviral therapy (HAART) was a major milestone in the attempt to recuperate HIV-1 infected individuals' immune systems. Despite this recuperation being slow, partial, and variable, the suppression of HIV-1 replication has permitted a higher level of control over associated diseases with a consequent decrease in mortality and improvement in quality of life. (10) The main surrogate markers of natural history and therapeutic efficacy currently used in HIV infected patient follow-up are clinical condition, CD 4 + T lymphocyte count, and plasma viral load (VL) determination (21, 23) . However, after VL drops below detectable levels, it does not allow us to consistently express the behavior of immune response reconstitution. Also, CD 4 + T lymphocyte count can show irregular behavior without significant elevation even in individuals with major clinical improvement (4) and not demonstrate whether this elevation expresses the real immune system reconstitution through the production of naive cells, which have CD 45 RA surface molecules, or just the recirculation of memory cells, also known as CD 45 RO (10, 13, 20) . In addition, CD4 + T lymphocyte count does not characterize the quality of the immunomodulatory substances they produce.
Other indices might be useful for a better evaluation of these patients' immune reconstitution, considering both qualitative and quantitative aspects. From these we can highlight serum cytokine profile (1, 5, 6, 7, 9, 17, 22, 26, 28) and CD 45 RA and CD 45 RO cell count. (10, 13, 20) Sera aliquots were stored at -70°C for determination of TNF-α, IFN-γ, IL-2, IL-4, and IL-10 cytokines; levels were determined by ELISA using commercial kits (R&D Systems).
The assay detection limit varied from 3 to 5 pg/ml, depending on the cytokine.
HIV-1 VL was determined using NucliSens HIV-1 QT (Organon Teknika). The assay detection limit was 80 copies of plasma RNA/ml. Table 3 shows groups distribution according to sex and age. Males predominated in all groups, except G1. Mean age between groups was from 31 to 41 years. The highest mean age in HIV-1 infected groups was in G3. The mean age of HIV-1 individuals was Groups were not homogeneous to ARV treatment regimens as they were grouped using this parameter. G1 patients had not yet been treated; six G2 patients received two NRTI associated with one NNRTI, and three G2 patients, two NRTI associated with one PI; 11 G3 patients received two NRTI associated with one PI, and four G3 received two NRTI and one NNRTI. Although there was no significant difference between groups under treatment, PI tended to predominate in G3 (χ 2 1 =3.70; p<0.10). At exams collection, G1 had the highest number of individuals (six) with AIDS defining diseases; there were also 2 oligosymptomatic and 5 asymptomatic patients. In G2, asymptomatic was predominant; there were no oligosymptomatic, and only one individual with AIDS, who showed paradoxical reaction to tuberculosis. All G3 were asymptomatic.
Statistical Analysis

RESULTS
Analyzing data from Table 4 , statistical difference was seen between G1, and G3 and GC-2 for CD 45 RA cell count, with patients in G1 showing lower counts than those in G3 and GC-2 which were similar, and between G1, G3, and GC-2 for CD 45 RO cell count, with G1
showing lower counts than GC-2, and GC-2 patients showing lower counts than G3. Table 4 shows patient characterization in relation to serum cytokine level determination.
There was a progressive TNF-α serum level decrease from G1 to G3, and all showed higher TNF-α than GC-1. Statistical difference was seen between G1 and G2, G3, and GC-1 for IL-2, with serum levels in G1 being less elevated than in groups G2, G3, and GC-1, which had no statistical difference between them. There was no difference in IFN-γ serum levels between G1 and GC-1, but they were less elevated than in G2 and G3, which were not statistically different either. There was no statistical difference between G1, G2 and G3 for IL-10 and IL-4 serum levels, however these were higher than in GC-1 individuals. Statistical difference was seen for serum cytokine profile with predominance of profile 2 in G1, and pronounced predominance of mature profile 0 in G2 and G3 (χ According to data in Table 4 , there was statistical difference between groups for CD 4 + T lymphocyte count with progressive increase from G1 to G3; this did not occur with CD 8 + T lymphocyte count.
In G1, all individuals had detectable VL and in G2 there were seven undetectable and two detectable VL patients; in G3 there were nine undetectable and six were greater than 80 copies/ml; statistical difference was seen between groups, with G1 being statistically greater than both G2 and G3 which had no difference between them (Table   4) . Table 5 In relation to patient homogeneity, the sex behavior, age and transmission mechanism are in agreement with the most recent epidemiological condition of HIV-1 infected individuals in Brazil (18) .
Predominance of infected individuals with AIDS defining diseases among untreated patients is strong evidence for the benefit of the treatment (11) . At pretreatment phase, IFN-γ levels were statistically equal to those of normal individuals, increasing significantly with treatment, which is in agreement with Imami et al. (12) . This increase may be explained by the maintenance of large quantities of CD 8 + T lymphocytes, which are the main IFN-γ producers. (8) IL-4 and IL-10 were not statistically different between infected groups as treatment went on, but were always higher than in controls. However, in absolute values, in the pretreatment group, they were higher than in the other infected groups; this is in agreement with Imami et al. (12) .
Characterization of serum cytokine profiles in patients from the three study groups showed none with profile 1 (Th-1). Most studied patients were considered as having mature 0 profile (Th-0), or 2 (Th-2). Meira et al. (19) 
